Predicting Binding Free Energies of PDE2 Inhibitors. The Difficulties of Protein Conformation

Sci Rep. 2018 Mar 20;8(1):4883. doi: 10.1038/s41598-018-23039-5.

Abstract

A congeneric series of 21 phosphodiesterase 2 (PDE2) inhibitors are reported. Crystal structures show how the molecules can occupy a 'top-pocket' of the active site. Molecules with small substituents do not enter the pocket, a critical leucine (Leu770) is closed and water molecules are present. Large substituents enter the pocket, opening the Leu770 conformation and displacing the waters. We also report an X-ray structure revealing a new conformation of the PDE2 active site domain. The relative binding affinities of these compounds were studied with free energy perturbation (FEP) methods and it represents an attractive real-world test case. In general, the calculations could predict the energy of small-to-small, or large-to-large molecule perturbations. However, accurately capturing the transition from small-to-large proved challenging. Only when using alternative protein conformations did results improve. The new X-ray structure, along with a modelled dimer, conferred stability to the catalytic domain during the FEP molecular dynamics (MD) simulations, increasing the convergence and thereby improving the prediction of ΔΔG of binding for some small-to-large transitions. In summary, we found the most significant improvement in results when using different protein structures, and this data set is useful for future free energy validation studies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Binding Sites
  • Biophysical Phenomena
  • Crystallography, X-Ray / methods
  • Cyclic Nucleotide Phosphodiesterases, Type 2 / antagonists & inhibitors*
  • Cyclic Nucleotide Phosphodiesterases, Type 2 / chemistry
  • Cyclic Nucleotide Phosphodiesterases, Type 2 / metabolism
  • Entropy
  • Molecular Dynamics Simulation
  • Phosphodiesterase Inhibitors / chemistry*
  • Phosphodiesterase Inhibitors / metabolism*
  • Protein Binding
  • Protein Conformation
  • Proteins
  • Structure-Activity Relationship
  • Thermodynamics

Substances

  • Phosphodiesterase Inhibitors
  • Proteins
  • Cyclic Nucleotide Phosphodiesterases, Type 2